Screening of natural compounds and their derivatives as potential protein kinase C inhibitors

Drug Development Research

Volumn 63, Issue 2, 2004, Pages 76-87

  Tammela, Päivi ^a   Ekokoski, Elina ^a   García Horsman, Arturo ^a,b   Talman, Virpi ^a   Finel, Moshe ^a   Tuominen, Raimo ^a   Vuorela, Pia ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b Division de Neurobiologia   (Spain)

Author keywords

Flavonoids; Natural compounds; Protein kinase C; Screening

Indexed keywords

AURANTIIN; DODECYL GALLATE; EPICATECHIN GALLATE; EPIGALLOCATECHIN GALLATE; FLAVONOID; ISORHAMNETIN; KAEMPFEROL; LUTEOLIN; MYRICETIN; NATURAL PRODUCT; PHORBOL ESTER; PROTEIN KINASE C ALPHA; PROTEIN KINASE C INHIBITOR; QUERCETIN; RHAMNETIN; SCOPOLETIN;

ADOLESCENT; ANIMAL TISSUE; ARTICLE; DRUG MECHANISM; DRUG POTENCY; DRUG SCREENING; DRUG STRUCTURE; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME BINDING; ENZYME INHIBITION; IC 50; NONHUMAN; RAT; SIGNAL DETECTION; SIGNAL NOISE RATIO; SIGNAL TO BACKGROUND RATIO; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION;

EID: 13244273432     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/ddr.10399     Document Type: Article

References (51)

1. Agullo G, Gamet-Payrastre L, Manenti S, Viala C, Rémésy C, Chap H, Payrastre B. 1997. Relationship between flavonoid structure and inhibition of phosphatidylinositol 3-kinase: a comparison with tyrosine kinase and protein kinase C inhibition. Biochem Pharmacol 53:1649-1657.
2. Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe SI, Itoh N, Shibuya M, Fukami Y. 1987. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 262:5592-5595.
3. Birt DF, Hendrich S, Wang W. 2001. Dietary agents in cancer prevention: flavonoids and isoflavonoids. Pharmacol Ther 90: 157-177.
4. Bollini S, Herbst JJ, Gaughan GT, Verdoorn TA, Ditta J, Dubowchik GM, Vinitsky A. 2002. High-throughput fluorescence polarization method for identification of FKBP12 ligands. J Biomol Screen 7:526-530.
5. Bradford MM. 1976. A rapid and sensitive method for quantification of microgram quantities of proteins utilizing the principal of protein-dye binding. Anal Biochem 72:238-259.
6. Cacace AM, Guadagno SN, Krauss RS, Fabbro D, Weinstein IB. 1993. The epsilon isoform of protein kinase C is an oncogene when overexpressed in rat fibroblasts. Oncogene 8:2095-2104.
7. Chakravarthy BR, Bussey A, Whitfield JF, Sikorska M, Williams RE, Durkin JP. 1991. The direct measurement of protein kinase C (PKC) activity in isolated membranes using a selective peptide substrate. Anal Biochem 196:144-150.
8. Cohen P. 2002. Protein kinases: the major drug targets of the twenty-first century? Nat Rev Drug Discov 1:309-315.
9. Connolly JM, Rose DP. 1997. Expression of the invasive phenotype by MCF-7 human breast cancer cells transfected to overexpression protein kinase C-α or the erbB2 proto-oncogene. Int J Oncol 10:71-76.
10. Csukai M, Mochly-Rosen D. 1999. Pharmacologic modulation of protein kinase C isozymes: the role of RACKs and subcellular localisation. Pharmacol Res 39:253-259.
11. Dean N, McKay R, Miraglia L, Howard R, Cooper S, Giddings J, Nicklin P, Meister L, Ziel R, Geiger T, Muller M, Fabbro D. 1996. Inhibition of growth of human tumor cell lines in nude mice by an antisense oligonucleotide inhibitor of protein kinase C-α expression. Cancer Res 56:3499-3507.
12. Dempsey EC, Newton AC, Mochly-Rosen D, Fields AP, Reyland ME, Insel PA, Messing RO. 2000. Protein kinase C isozymes and the regulation of diverse cell responses. Am J Physiol Lung Cell Mol Physiol 279:L429-L438.
13. Dixon RA, Ferreira D. 2002. Genistein. Phytochemistry 60:205-211.
14. Engel GL, Farid NA, Faul MM, Richardson LA, Winneroski LL. 2000. Salt form selection and characterization of LY333531 mesylate monohydrate. Int J Pharm 198:239-247.
15. Ferriola PC, Cody V, Middleton E Jr. 1989. Protein kinase C inhibition by flavonoids. Kinetic mechanisms and structure-activity relationships. Biochem Pharmacol 38:1617-1624.
16. Gamet-Payrastre L, Manenti S, Gratacap MP, Tulliez J, Chap H, Payrastre B. 1999. Flavonoids and the inhibition of PKC and PI 3-kinase. Gen Pharmacol 32:279-286.
17. Gopalakrishna R, Chen ZH, Gundimeda U, Wilson JC, Anderson WB. 1992. Rapid filtration assays for protein kinase C activity and phorbol ester binding using multiwell plates with fitted filtration discs. Anal Biochem 206:24-35.
18. Gutcher I, Webb PR, Anderson NG. 2003. The isoform-specific regulation of apoptosis by protein kinase C. Cell Mol Life Sci 60:1061-1070.
19. Han C. 1997. Screening of anticarcinogenic ingredients in tea polyphenols. Cancer Lett 114:153-158.
20. Harborne JB, Williams CA. 2000. Advances in flavonoid research since 1992. Phytochemistry 55:481-504.
21. Hu H. 1996. Recent discovery and development of selective protein kinase C inhibitors. Drug Discov Today 1:438-447.
22. Jirousek MR, Gillig JR, Gonzalez CM, Heath WF, McDonald JH III, Neel DA, Rito CJ, Singh U, Stramm LE, Melikian-Badalian A, Baevsky M, Ballas LM, Hall SE, Winneroski LL, Faul MM. 1996. (S)-13-[(Dimethylamino)methyl]-10,11,14,15- tetrahydro-4,9:16,21-dimetheno-1H,13H-dibenzo[e,k]]pyrrolo[3,4-h][1,4,13] oxadiazacyclohexadecene-1,3(2H)-dione (LY333531) and related analogues: isoenzyme selective inhibitors of protein kinase Cβ. J Med Chem 39:2664-2671.
23. Kang TB, Liang NC. 1997. Studies on the inhibitory effects of quercetin on the growth of HL-60 leukemia cells. Biochem Pharmacol 54:1013-1018.
24. Kikkawa U, Minakuchi R, Takai Y, Nishizuka Y. 1983. Calcium-activated, phopsholipid-dependent protein kinase (protein kinase C) from rat brain. Methods Enzymol 99:288-298.
25. Kimata M, Shichijo M, Miura T, Serizawa I, Inagaki N, Nagai H. 2000. Effects of luteolin, quercetin, and baicalein on immunoglobulin E-mediated mediator release from human cultured mast cells. Clin Exp Allergy 30:501-508.
26. Kishimoto A, Kikkawa U, Ogita K, Shearman MS, Nishizuka Y. 1989. The protein kinase C family in the brain: heterogeneity and its implications. Ann NY Acad Sci 568:181-186.
27. Kitano K, Nam KY, Kimura S, Fujiki H, Imanishi Y. 1997. Sealing effects of (-)-epigallocatechin gallate on protein kinase C and protein phosphatase 2A. Biophys Chem 65:157-164.
28. Lambert JD, Yang CS. 2003. Cancer chemopreventive activity and bioavailability of tea and tea polyphenols. Mutat Res 523-524:201-208.
29. Lampe JW, Biggers CK, Defauw JM, Foglesong RJ, Hall SE, Heerding JM, Hollinshead SP, Hu H, Hughes PF, Jagdmann E Jr, Johnson MG, Lai YS, Lowden CT, Lynch MP, Mendoza JS, Murphy MM, Wilson JW, Ballas LM, Carter K, Darges JW, Davis JE, Hubbard FR, Stamper ML. 2002. Synthesis and protein kinase inhibitory activity of balanol analogues with modified benzophenone subunits. J Med Chem 45:2624-2643.
30. Lee SF, Lin JK. 1997. Inhibitory effects of phytopolyphenols on TPA-induced transformation, PKC activation, and c-jun expression in mouse fibroblast cells. Nutr Cancer 28:177-183.
31. Liang YC, Lin-Shiau SY, Chen CF, Lin JK. 1997. Suppression of extracellular signals and cell proliferation through EGF receptor binding by (-)- epigallocatechin gallate in human A431 epidermoid carcinoma cells. J Cell Biochem 67:55-65.
32. Lin JK, Chen YC, Huang YT, Lin-Shiau SY. 1997. Suppression of protein kinase C and nuclear oncogene expression as possible molecular mechanisms of cancer chemoprevention by apigenin and curcumin. J Cell Biochem 28/29(Suppl):39-48.
33. López-Lázaro M, Gálvez M, Martín-Cordero C, Ayuso MJ. 2002. Cytotoxicity of flavonoids on cancer cell lines. Structure-activity relationship. Stud Nat Prod Chem 27:891-932.
34. Matassa AA, Carpenter L, Biden TJ, Humphries MJ, Reyland ME. 2001. PKCδ is required for mitochondrial-dependent apoptosis in salivary epithelial cells. J Biol Chem 276:29719-28728.
35. Mellor H, Parker PJ. 1998. The extended protein kinase C superfamily. Biochem J 332:281-292.
36. 1 activated protein kinase C by phenolic compounds. Cancer Lett 121:99-104.
37. Nardini M, Scaccini C, Packer L, Virgili F. 2000. In vitro inhibition of the activity of phosphorylase kinase, protein kinase C and protein kinase A by caffeic acid and a procyanidin-rich pine bark (Pinus marittima) extract. Biochim Biophys Acta 1474: 219-225.
38. Newton AC. 1997. Regulation of protein kinase C. Curr Opin Cell Biol 9:161-167.
39. Nick A, Rali T, Sticher O. 1995. Biological screening of traditional medicinal plants from Papua New Guinea. J Ethnopharmacol 49:147-156.
40. Russo M, Palumbo R, Mupo A, Tosto M, Iacomino G, Scognamiglio A, Tedesco I, Galano G, Russo GL. 2003. Flavonoid quercetin sensitizes a CD95-resistant cell line to apoptosis by activating protein kinase Cα. Oncogene 22:3330-3342.
41. Sarkar FH, Li Y. 2002. Mechanisms of cancer chemoprevention by soy isoflavone genistein. Cancer Metastasis Rev 21:265-280.
42. Schechtman D, Mochly-Rosen D. 2001. Isoenzyme-specific inhibitors and activators of protein kinase C. Methods Enzymol 345:470-489.
43. Sittampalam GS, Iversen PW, Boadt JA, Kahl SD, Bright S, Zock JM, Janzen WP, Lister MD. 1997. Design of signal windows in high throughput screening assays for drug discovery. J Biomol Screen 2:159-169.
44. Vlahos CJ, Matter WF, Hui KY, Brown RF. 1994. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J Biol Chem 269:5241-5248.
45. Wang BH, Polya GM. 1996. Selective inhibition of cyclic AMP-dependent protein kinase by amphiphilic triterpenoids and related compounds. Phytochemistry 41:55-63.
46. Wang BH, Ternai B, Polya G. 1997. Specific inhibition of cyclic AMP-dependent protein kinase by warangalone and robustic acid. Phytochemistry 44:787-796.
47. Wang BH, Lu ZX, Polya GM. 1998. Inhibition of eukaryote serine/ threonine-specific protein kinases by piceatannol. Planta Med 64:195-199.
48. Wang SI, Mukhtar H. 2002. Gene expression profile in human prostate LNCaP cancer cells by (-) epigallocatechin-3-gallate. Cancer Lett 182:43-51.
49. Yang EB, Zhao YN, Zhang K, Mack P. 1999. Daphnetin, one of coumarin derivatives, is a protein kinase inhibitor. Biochem Biophys Res Commun 260:682-685.
50. Zhang JH, Chung TDY, Oldenburg KR. 1999. A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen 4:67-73.
51. Zhou BN, Bahler BD, Hofmann GA, Mattern MR, Johnson RK, Kingston DGI. 1998. Phenylethanoid glycosides from Digitalis purpurea and Penstemon linarioides with PKCα-inhibitory activity. J Nat Prod 61:1410-1412.